Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：CT26-hTNFRSF1B Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230002
TNFRSF1B gene humanized CT26 cell line
Strain Name：CT26-hCLDN6 Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230004
CLDN6 gene humanized CT26 cell line
Strain Name：CT26-hGDF15 Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230012
GDF15 gene humanized CT26 cell line
Strain Name：LLC-hCLDN6 Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230003
CLDN6 gene humanized LLC1/LL2 cell line
Strain Name：LLC-hMSLN Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230019
MSLN gene humanized LLC1/LL2 cell line
Strain Name：CT26-hEpCAM-Luc Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230035
EPCAM gene humanized CT26 cell line
Strain Name：MC38-hCLDN6 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230005
CLDN6 gene humanized MC38 cell line
Strain Name：B16F10-hCD47/Sirpa Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230058
CD47 gene humanized B16F10 cell line with Sirpa gene overexpression
Strain Name：Hepa1-6-hMSLN Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230020
MSLN gene humanized Hepa1-6 cell line
Strain Name：B16F10-hCD47-Sirpa-KO Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230061
CD47 gene humanized B16F10 cell line with Sirpa gene knockdown
Please fill in the order form and we will contact you within 2 working days.
